Showing results (611-620 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|November 28, 2012
Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infectionKristian Thorlund, Eric Druyts, Antoine C El Khoury, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 4, 2012
Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulationSoroush Mortaz, Christine Wessman, Ross Duncan, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 21, 2012
Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitisSteen M Rønborg, Ulrik G Svendsen, Jesper S Micheelsen, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 15, 2013
Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelinesGiorgio L Colombo, Sergio Di Matteo, Andrea Antinori, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 21, 2018
Cost-consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHSLaura Amanda Vallejo-Aparicio, Germán Peces-Barba, Alicia Gil, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 21, 2018
Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in MexicoRayo Morfín-Otero, Martha Alvarado-Ibarra, Eduardo Rodriguez-Noriega, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 17, 2018
The role of a best practice alert in the electronic medical record in reducing repetitive lab testsHarini Bejjanki, Lazarus K Mramba, Stacy G Beal, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 28, 2017
Community-based health insurance and communities' scheme requirement compliance in Thehuldere district, northeast Ethiopia: cross-sectional community-based studySamuel Getachew Workneh, Gashaw Andargie Biks, Solomon Assefa Woreta
Clinicoeconomics and Outcomes Research : CEOR|May 23, 2019
Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthmaElizabeth A Brooks, Marc Massanari, Nicola A Hanania, et al.
Pageof 102